A detailed history of Titleist Asset Management, Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 19,991 shares of JNJ stock, worth $2.92 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
19,991
Previous 21,344 6.34%
Holding current value
$2.92 Million
Previous $3.49 Million 1.26%
% of portfolio
0.83%
Previous 0.8%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$160.2 - $179.79 $216,750 - $243,255
-1,353 Reduced 6.34%
19,991 $0
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $120,836 - $134,460
-749 Reduced 3.39%
21,344 $3.49 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $61,221 - $67,707
-364 Reduced 1.62%
22,093 $3.92 Million
Q1 2022

May 04, 2022

BUY
$158.14 - $179.59 $483,433 - $549,006
3,057 Added 15.76%
22,457 $3.98 Million
Q4 2021

Feb 17, 2022

BUY
$155.93 - $173.01 $3.03 Million - $3.36 Million
19,400 New
19,400 $3.32 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Titleist Asset Management, Ltd. Portfolio

Follow Titleist Asset Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, Ltd. with notifications on news.